Inhibitors of cyclin dependent kinases as anti-cancer agent

Details Inhibitors of cyclin dependent kinases as anti-cancer agent Inhibitors of cyclin dependent kinases as anti-cancer agent

2007-08-28

2007-08-28

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C544S331000, C548S537000

Reexamination Certificate

active

10671747

ABSTRACT:
The present invention relates to 2-substituted 4-heteroaryl-pyrimidines, their preparation, pharmaceutical compositions containing them and their use as inhibitors of cyclin-dependent kinases (CDKs) and hence their use in the treatment of proliferative disorders such as cancer, leukaemia, psoriasis and the like.

REFERENCES:
patent: 2003/0092714 (2003-05-01), Cao et al.
patent: 2003/0203926 (2003-10-01), Kois et al.
patent: 0 233 461 (1987-08-01), None
patent: 0 588 762 (1992-08-01), None
patent: WO95/09852 (1995-04-01), None
patent: WO97/19065 (1997-05-01), None
patent: WO 00/39101 (2000-07-01), None
patent: WO 02/46171 (2002-06-01), None
Torley et al., CAPLUS Abstract 18:112478 (RN 112722-32-4), 1988.
Simone, Oncology: Introduction, Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
Blain et al., Differential Interaction of thet Cyclin-dependent Kinase (Cdk) inhibitor p27 with Cyclin-A-Cdk2 and Cyclin D2-Cdk4, The Journal of Biological Chemistry, vol. 272, No. 41, pp. 25863-25872, 1997.
LuValle et al., Cell Cycle Control in Growth Plate Chondrocytes, Frontiers in Bioscience 5, d493-503, May 2000.

Affiliated with

Also associated with

Rating

Inhibitors of cyclin dependent kinases as anti-cancer agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibitors of cyclin dependent kinases as anti-cancer agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of cyclin dependent kinases as anti-cancer agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3854597